Prednisolone Impurity 16
 
		Product Description
CAT No.
				
									ALN-P027067								
				CAS No.
				
									NA								
				Mol. F.
				
									C21H26O5								
				Mol. Wt.
				
									358.4								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 2-((8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid								
				
									Smiles : C[C@@](C(CC1)=CC2=O)(C=C2)[C@]3([H])[C@]1([H])[C@@](CC[C@@H]4C(C(O)=O)=O)([H])[C@]4(C)C[C@@H]3O								
				
									Inchi : InChI=1S/C20H26O4/c1-19-8-7-12(21)9-11(19)3-4-13-14-5-6-15(18(23)24)20(14,2)10-16(22)17(13)19/h7-9,13-17,22H,3-6,10H2,1-2H3,(H,23,24)/t13-,14-,15+,16-,17+,19-,20-/m0/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Validated stability indicating RP-LC assay for determination of gatifloxacin and prednisolone acetatein ophthalmic preparations and biological samples
									By Qadir, Muhammad A.; Shahzad, Shabnam; Ahmed, Mahmood; Razzaq, Syed S.; Shafiq, Muhmmad I.nFrom Latin American Journal of Pharmacy (2016), 35(5), 912-920								
				Novel stability indicating RP-HPLC method for the simultaneous estimation of moxifloxacin and prednisolone in bulk and their combined dosage form
									By Potnuri, Naga Raju; Rao, G. Devala; Prasad, Y. Rajendra – From International Journal of Pharmaceutical Sciences and Research (2015), 6(5), 1965-1973 								
				Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension
									By Marley, Adrian; Stalcup, Apryll M.; Connolly, Damian – From Journal of Pharmaceutical and Biomedical Analysis (2015), 102, 261-266								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            